1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
|
|
|
- CAS-Nr.
- 2102675-40-9
- Englisch Name:
- 1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
- Synonyma:
- Lucitinib Impurity 3;Lucitinib Impurity 5;Ruxolitinib Impurity 09;Ruxolitinib Impurity 05;Ruxolitinib Phosphate Impurity 11;1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-;(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropionic acid;(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid;(3R)-3-Cyclopentyl-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic acid;(βR)?-β-?Cyclopentyl-?4-?(7H-?pyrrolo[2,?3-?d]?pyrimidin-?4-?yl)?-1H-?pyrazole-?1-?propanoic Acid
- CBNumber:
- CB58186873
- Summenformel:
- C17H19N5O2
- Molgewicht:
- 325.37
- MOL-Datei:
- 2102675-40-9.mol
|
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- Eigenschaften
- Dichte
- 1.50±0.1 g/cm3(Predicted)
- pka
- 4.30±0.10(Predicted)
Sicherheit
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
(βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanoic Acid is a useful reagent for preparing Ruxolitinib (R702000(P)), which is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. It is also a potent JAK2 inhibitor.
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 40)Lieferanten
- 1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
- (βR)?-β-?Cyclopentyl-?4-?(7H-?pyrrolo[2,?3-?d]?pyrimidin-?4-?yl)?-1H-?pyrazole-?1-?propanoic Acid
- (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid
- (3R)-3-Cyclopentyl-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic acid
- Lucitinib Impurity 3
- (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid (Ruxolitinib Impurity)
- (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropionic acid
- Ruxolitinib Impurity 05
- Ruxolitinib Impurity 09
- Lucitinib Impurity 5
- Ruxolitinib Phosphate Impurity 11
- 2102675-40-9
